Toggle navigation
Home
Search
Services
Blog
Contact
About
Cloning and Expression of Recombinant Htlv-II
Dolby, Nichol
Hawaii Biotech, Inc., Aiea, HI, United States
Search grants from Nichol Dolby
Search grants from Hawaii Biotech, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Animal model of impaired autoregulation for study of age related vascular cognitive impairment
Effector and regulatory T cell responses and protection from clinical malaria
Developmental regulation by miRNAs
Regulation of Isoactin Dynamics in Living Cells
Characterization of Newly-Identified Protein Kinases
Recently added grants:
Administrative Core
Endocytic Regulation of Intestinal Development
Relaxin receptor agonists for treatment of liver fibrosis
Translational Biomarker Analytical Core (TBAC)
CD73 is a multi-functional protein that regulates liver injury
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Epidemiology And Genetics (NCI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43CP005695-002
Application #
3626522
Study Section
Project Start
1991-03-28
Project End
Budget Start
1991-03-28
Budget End
1991-04-30
Support Year
Fiscal Year
1991
Total Cost
Indirect Cost
Institution
Name
Hawaii Biotech, Inc.
Department
Type
DUNS #
113226823
City
Aiea
State
HI
Country
United States
Zip Code
96701
Related projects
NIH 1991
N43 CP
Cloning and Expression of Recombinant Htlv-II
Dolby, Nichol / Hawaii Biotech, Inc.
NIH 1990
N43 CP
Cloning and Expression of Recombinant Htlv-II
Dolby, Nichol / Hawaii Biotech, Inc.
Comments
Be the first to comment on Nichol Dolby's grant